ArticleJASA express letters2025
Comparing manual and automated methods for calculating speaking rate in Parkinson's disease.
Article in JASA express letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- "Does speech in patients with different Parkinson's disease subtypes decline over time?"Clinical parkinsonism & related disorders · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study compared manual and automated methods for calculating speaking rate in recorded samples from individuals with Parkinson's disease. The manual procedure involved trained researchers measuring speaking rate through manual counting and acoustic analysis of speech units and pauses, while the automated method utilized a custom praat script developed by de Jong and Wempe [(2009). Behav. Res. Methods 41(2), 385-390]. Results indicated moderate agreement between methods, strongest when the automated script was optimized per speaker. Despite the limitations of an automated approach, this research supports the potential of automation in speaking rate analysis and provides a basis for future refinement in clinical and research contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.